Furthermore, a significant positive correlation exists between elevated S100A8/A9 concentrations and poor clinical outcomes, including increased 28-day mortality in sepsis patients (Simm et al., 2016; Larsson et al., 2020). This evidence concerns the gene S100A8 and Sepsis.